or Try an Advanced Search...

    Technical Analysis for DTIL - Precision BioSciences, Inc.

    Grade Last Price % Change Price Change
    F 11.80 -2.40% -0.29
    DTIL closed up 4.04 percent on Wednesday, May 15, 2024, on 89 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Its advance stalled at its 200 day moving average, an important long-term support / resistance line. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical DTIL trend table...
    Date Alert Name Type % Chg
    200 DMA Resistance Bearish -2.40%
    Shooting Star Candlestick Bearish -2.40%
    Crossed Above 50 DMA Bullish -2.40%
    Pocket Pivot Bullish Swing Setup -2.40%
    NR7 Range Contraction -2.40%
    Stochastic Reached Overbought Strength -2.40%
    Weak + Overbought Other -2.40%
    Weak, Overbought and Reversal Signs Reversal -2.40%
    Above Upper BB Strength -2.40%
    Gapped Up Strength -2.40%
    Older End-of-Day Signals for DTIL ...

       Recent Intraday Alerts

    Alert Time
    Down 2 % 41 minutes ago
    Fell Below 50 DMA about 1 hour ago
    Shooting Star Candlestick Entry about 1 hour ago
    Fell Below Previous Day's Low about 1 hour ago
    Down 1% about 1 hour ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    DTIL Chart by TradingView
    Basic chart:

    Profile

    Precision BioSciences is dedicated to improving life (DTIL) through its proprietary genome editing platform, “ARCUS.” Precision leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and create healthy and sustainable food and agriculture solutions. Precision is actively developing product candidates in three innovative areas: allogeneic CAR T immunotherapy, in vivo gene correction, and food.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Immunotherapy Cancer Treatment Virotherapy Human Diseases Genome Genome Editing

    Is DTIL a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 13 Precision BioSciences GAAP EPS of $1.70, revenue of $17.58M beats by $11.56M
    May 13 Precision BioSciences Reports First Quarter 2024 Financial Results and Provides Business Update
    May 10 Precision BioSciences Q1 Earnings Preview
    May 8 Precision BioSciences Announces Common Stock Purchase by Members of Management for $300,000 in a Private Placement
    May 7 Precision BioSciences to Report First Quarter Results on May 13, 2024
    May 7 Precision BioSciences Announces Receipt of FDA Fast Track Designation for ECUR-506, iECURE’s Program for the Treatment of Neonatal Onset Ornithine Transcarbamylase (OTC) Deficiency
    May 1 Precision BioSciences Announces Late-Breaking Poster Presentation at the European Association for Study of the Liver (EASL) Congress 2024
    Apr 17 Intra-Cellular (ITCI) Moves 23.3% Higher: Will This Strength Last?
    Apr 16 Eli Lilly subsidiary, Precision Biosciences end gene therapy collaboration
    Apr 16 Precision BioSciences Announces Return of Programs and Conclusion of Collaboration with Prevail Therapeutics
    See more DTIL news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 27.015
    52 Week Low 8.25
    Average Volume 99,015
    200-Day Moving Average 12.10
    50-Day Moving Average 11.94
    20-Day Moving Average 10.53
    10-Day Moving Average 11.06
    Average True Range 0.90
    RSI (14) 56.52
    ADX 16.38
    +DI 28.23
    -DI 18.43
    Chandelier Exit (Long, 3 ATRs) 10.50
    Chandelier Exit (Short, 3 ATRs) 11.85
    Upper Bollinger Bands 11.94
    Lower Bollinger Band 9.13
    Percent B (%b) 1.05
    BandWidth 26.64
    MACD Line -0.17
    MACD Signal Line -0.43
    MACD Histogram 0.2599
    Fundamentals Value
    Market Cap 1.47 Billion
    Num Shares 122 Million
    EPS -0.86
    Price-to-Earnings (P/E) Ratio -14.06
    Price-to-Sales 0.94
    Price-to-Book 1.60
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 12.99
    Resistance 3 (R3) 13.03 12.77 12.84
    Resistance 2 (R2) 12.77 12.54 12.75 12.79
    Resistance 1 (R1) 12.43 12.40 12.60 12.39 12.74
    Pivot Point 12.17 12.17 12.26 12.15 12.17
    Support 1 (S1) 11.83 11.94 12.00 11.79 11.44
    Support 2 (S2) 11.57 11.80 11.55 11.39
    Support 3 (S3) 11.23 11.57 11.34
    Support 4 (S4) 11.19